drugset / Trial / NCT00357916

Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design

NCT00357916

Phase 1 Completed 200 enrolled Peplin
RandomizedParallel-groupOpen-labelDiagnostic

Summary

To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation

Timeline

Start
2006-06
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.01 % Topical

Indications

No indication recorded.